| |||||||||
| Login :: Register :: Search forums :: Top Users :: Reagent |
|
Position: Discussion forums > Bioscience biotechniques discussion forums > Proteomics and protein biochemistry forum
|
Do you work with human specimens? NCI Symposium on biospecimens in March
Posted by: markd (IP Hidden, New member, 3)
Date: January 22, 2008 01:16PM
The National Cancer Institute Office of Biorepositories and Biospecimen Research (OBBR) and the National Institutes of Health Office of Rare Diseases announce the Biospecimen Research Network (BRN) Symposium:
Advancing Cancer Research Through Biospecimen Science March 1314, 2008 Renaissance M Street Hotel 1143 New Hampshire Avenue NW Washington, D.C. The primary goal of the symposium is to address the significant impact of pre-analytical biospecimen variability on cancer research and molecular medicine. The symposium will feature expert presentations and interactive discussions on topics in biospecimen science including: HER2/neu: Lessons Learned Access to Existing Knowledge in Biospecimen Science Research Advances in Biospecimen Science Assessing and Qualifying Biospecimen Quality Patient Perspective Incorporating Biospecimen Science into Research and Clinical Practice Key presenters to address the significant impact of biospecimen variability in cancer research and recent advances in biospecimen science include: Carolyn Compton, M.D., Ph.D. (NCI/OBBR) Pat Brown, M.D., Ph.D. (Stanford Univ.) Angelo DeMarzo, M.D., Ph.D. (John Hopkins University) Steve Gutman, M.D., M.B.A. (FDA) Elizabeth Hammond, M.D. (University of Utah, LDS Hospital) Daniel Hayes, M.D. (University of Michigan) Paul Waring, MBBS, FRCPA, Ph.D. (Genentech) David Ransohoff, M.D. (University North Carolina, Chapel Hill) Scott Jewell, Ph.D. (Ohio State University) Paula Kim (TRACO, Translating Research Across Communities) Gerry Thomas, Ph.D. (Wales Cancer Center, Cardiff, UK) Chris Logothetis, M.D. (M.D. Anderson Cancer Center) Theo de Vos, Ph.D. (Epigenomics AG) and others This interactive symposium is open to the public and expected to be of particular value to research investigators, clinicians, government representatives, industry representatives, hospital administrators, and patient advocates. For more information, to register, and to submit an abstract, please visit www.brnsymposium.com. We apologize if you receive more than one copy of this notice. Please share this notice with any interested colleagues. We look forward to your participation. If you have any questions about the meeting or registration, please contact Marlene Goldman at mgoldman@md.capconcorp.com or 301-468-6004 ext. 416.
|
We are moving ... Please post to our new community forums
|
|
||||||||